| Year |
Citation |
Score |
| 2022 |
Bhattarai RS, Bariwal J, Kumar V, Hao C, Deng S, Li W, Mahato RI. pH-sensitive nanomedicine of novel tubulin polymerization inhibitor to lung metastatic melanoma. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 36037976 DOI: 10.1016/j.jconrel.2022.08.023 |
0.655 |
|
| 2022 |
Kumar V, Sethi B, Yanez E, Leung DH, Ghanwatkar YY, Cheong J, Tso J, Narang AS, Nagapudi K, Mahato RI. Effect of magnesium stearate surface coating method on the aerosol performance and permeability of micronized fluticasone propionate. International Journal of Pharmaceutics. 615: 121470. PMID 35041913 DOI: 10.1016/j.ijpharm.2022.121470 |
0.576 |
|
| 2020 |
Bhattarai RS, Kumar V, Romanova S, Bariwal J, Chen H, Deng S, Bhatt VR, Bronich T, Li W, Mahato RI. Nanoformulation design and therapeutic potential of a novel tubulin inhibitor in pancreatic cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33010334 DOI: 10.1016/j.jconrel.2020.09.052 |
0.654 |
|
| 2020 |
Kumar V, Bariwal J, Narang AS, Tso J, Cheong J, Mahato RI. Functional similarity of modified cascade impactor to deposit drug particles on cells. International Journal of Pharmaceutics. 119404. PMID 32387312 DOI: 10.1016/J.Ijpharm.2020.119404 |
0.754 |
|
| 2020 |
Wang Q, Kumar V, Lin F, Sethi B, Coulter DW, McGuire TR, Mahato RI. ApoE mimetic peptide targeted nanoparticles carrying a BRD4 inhibitor for treating Medulloblastoma in mice. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 32380205 DOI: 10.1016/J.Jconrel.2020.04.053 |
0.339 |
|
| 2020 |
Peng Y, Bariwal J, Kumar V, Tan C, Mahato RI. Organic Nanocarriers for Delivery and Targeting of Therapeutic Agents for Cancer Treatment Advanced Therapeutics. 3: 1900136. DOI: 10.1002/adtp.201900136 |
0.645 |
|
| 2019 |
Kumar V, Dong Y, Kumar V, Almawash S, Mahato RI. The use of micelles to deliver potential hedgehog pathway inhibitor for the treatment of liver fibrosis. Theranostics. 9: 7537-7555. PMID 31695785 DOI: 10.7150/Thno.38913 |
0.404 |
|
| 2019 |
Bariwal J, Kumar V, Chen H, Bhattarai R, Yang P, Li W, Mahato RI. Nanoparticulate delivery of potent microtubule inhibitor for metastatic melanoma treatment. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 31330213 DOI: 10.1016/J.Jconrel.2019.07.025 |
0.701 |
|
| 2019 |
Yang R, Chen H, Guo D, Dong Y, Miller DD, Li W, Mahato RI. Polymeric Micellar Delivery of Novel Microtubule Destabilizer and Hedgehog Signaling Inhibitor for Treating Chemoresistant Prostate Cancer. The Journal of Pharmacology and Experimental Therapeutics. PMID 30996033 DOI: 10.1124/Jpet.119.256628 |
0.34 |
|
| 2019 |
Kumar V, Sethi B, Kumar V, Mcguire TR, Coulter DW, Mahato RI. Abstract 15: Targeting vismodegib-resistant medulloblastoma using novel hedgehog pathway inhibitor and miR-29b mimic Cancer Research. 79: 15-15. DOI: 10.1158/1538-7445.Sabcs18-15 |
0.319 |
|
| 2018 |
Bariwal J, Kumar V, Dong Y, Mahato RI. Design of Hedgehog pathway inhibitors for cancer treatment. Medicinal Research Reviews. PMID 30484872 DOI: 10.1002/Med.21555 |
0.668 |
|
| 2018 |
Lin F, Wen D, Wang X, Mahato RI. Dual responsive micelles capable of modulating miRNA-34a to combat taxane resistance in prostate cancer. Biomaterials. 192: 95-108. PMID 30447399 DOI: 10.1016/J.Biomaterials.2018.10.036 |
0.331 |
|
| 2018 |
Peng Y, Wen D, Lin F, Mahato RI. Co-delivery of siAlox15 and sunitinib for reversing the new-onset of type 1 diabetes in non-obese diabetic mice. Journal of Controlled Release : Official Journal of the Controlled Release Society. 292: 1-12. PMID 30393183 DOI: 10.1016/J.Jconrel.2018.10.032 |
0.339 |
|
| 2018 |
Kumar V, Mundra V, Peng Y, Wang Y, Tan C, Mahato RI. Pharmacokinetics and biodistribution of polymeric micelles containing miRNA and small-molecule drug in orthotopic pancreatic tumor-bearing mice. Theranostics. 8: 4033-4049. PMID 30128034 DOI: 10.7150/Thno.24945 |
0.328 |
|
| 2018 |
Su Q, Kumar V, Sud N, Mahato RI. Role of MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis. Advanced Drug Delivery Reviews. PMID 29391222 DOI: 10.1016/J.Addr.2018.01.009 |
0.347 |
|
| 2018 |
Almawash SA, Mondal G, Mahato RI. Coadministration of Polymeric Conjugates of Docetaxel and Cyclopamine Synergistically Inhibits Orthotopic Pancreatic Cancer Growth and Metastasis. Pharmaceutical Research. 35: 17. PMID 29305793 DOI: 10.1007/S11095-017-2303-3 |
0.309 |
|
| 2018 |
Chaudhary AK, Bhattarai RS, Mahato RI. The fourth annual BRDS on genome editing and silencing for precision medicines. Drug Delivery and Translational Research. 8: 266-272. PMID 29209906 DOI: 10.1007/S13346-017-0457-5 |
0.301 |
|
| 2017 |
Date T, Nimbalkar V, Kamat J, Mittal A, Mahato RI, Chitkara D. Lipid-polymer hybrid nanocarriers for delivering cancer therapeutics. Journal of Controlled Release : Official Journal of the Controlled Release Society. 271: 60-73. PMID 29273320 DOI: 10.1016/J.Jconrel.2017.12.016 |
0.305 |
|
| 2017 |
Mondal G, Almawash S, Chaudhary AK, Mahato RI. EGFR-Targeted Cationic Polymeric Mixed Micelles for Co-delivery of Gemcitabine and miR-205 for treating Advanced Pancreatic Cancer. Molecular Pharmaceutics. PMID 28719220 DOI: 10.1021/Acs.Molpharmaceut.7B00355 |
0.304 |
|
| 2017 |
Kumar V, Chaudhary AK, Dong Y, Zhong HA, Mondal G, Lin F, Kumar V, Mahato RI. Design, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic Cancer. Scientific Reports. 7: 1665. PMID 28490735 DOI: 10.1038/S41598-017-01942-7 |
0.32 |
|
| 2017 |
Yang R, Mondal G, Ness RA, Arnst K, Mundra V, Miller DD, Li W, Mahato RI. Polymer conjugate of a microtubule destabilizer inhibits lung metastatic melanoma. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 28130039 DOI: 10.1016/J.Jconrel.2017.01.028 |
0.346 |
|
| 2016 |
Dutta R, Kumar V, Peng Y, Evande RE, Grem JL, Mahato RI. Pharmacokinetics and Biodistribution of GDC-0449 Loaded Micelles in Normal and Liver Fibrotic Mice. Pharmaceutical Research. PMID 27995525 DOI: 10.1007/S11095-016-2081-3 |
0.325 |
|
| 2016 |
Kattel K, Mondal G, Lin F, Kumar V, Mahato RI. Biodistribution of Self-Assembling Polymer-Gemcitabine Conjugate after Systemic Administration into Orthotopic Pancreatic Tumor bearing Mice. Molecular Pharmaceutics. PMID 27798825 DOI: 10.1021/Acs.Molpharmaceut.6B00929 |
0.304 |
|
| 2016 |
Yang R, Mondal G, Wen D, Mahato RI. Combination Therapy of Paclitaxel and Cyclopamine Polymer-Drug Conjugates to Treat Advanced Prostate Cancer. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 27520724 DOI: 10.1016/J.Nano.2016.07.017 |
0.328 |
|
| 2016 |
Wen D, Peng Y, Liu D, Weizmann Y, Mahato RI. Mesenchymal Stem Cell and Derived Exosome as Small RNA Carrier and Immunomodulator to Improve Islet Transplantation. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27475298 DOI: 10.1016/J.Jconrel.2016.07.044 |
0.317 |
|
| 2016 |
Karaca M, Dutta R, Ozsoy Y, Mahato RI. Micelle Mixtures for Co-administration of Gemcitabine and GDC-0449 to treat Pancreatic Cancer. Molecular Pharmaceutics. PMID 26981724 DOI: 10.1021/Acs.Molpharmaceut.5B00971 |
0.37 |
|
| 2015 |
Peng Y, Dong Y, Mahato RI. Synthesis and Characterization of a Novel Mycophenolic Acid - Quinic Acid Conjugate Served as Immunosuppressant with Decreased Toxicity. Molecular Pharmaceutics. PMID 26529468 DOI: 10.1021/Acs.Molpharmaceut.5B00639 |
0.348 |
|
| 2015 |
Kumar V, Mondal G, Dutta R, Mahato RI. Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis. Biomaterials. 76: 144-156. PMID 26524535 DOI: 10.1016/J.Biomaterials.2015.10.047 |
0.4 |
|
| 2015 |
Wen D, Danquah M, Chaudhary AK, Mahato RI. Small molecules targeting microRNA for cancer therapy: Promises and obstacles. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26256260 DOI: 10.1016/J.Jconrel.2015.08.011 |
0.525 |
|
| 2015 |
Mundra V, Li W, Mahato RI. Nanoparticle-mediated drug delivery for treating melanoma. Nanomedicine (London, England). 10: 2613-33. PMID 26244818 DOI: 10.2217/Nnm.15.111 |
0.321 |
|
| 2015 |
Mundra V, Peng Y, Kumar V, Li W, Miller DD, Mahato RI. Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma. Drug Delivery and Translational Research. 5: 199-208. PMID 25924699 DOI: 10.1007/S13346-015-0226-2 |
0.348 |
|
| 2015 |
Kumar V, Mondal G, Slavik P, Rachagani S, Batra SK, Mahato RI. Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer. Molecular Pharmaceutics. 12: 1289-98. PMID 25679326 DOI: 10.1021/Mp500847S |
0.315 |
|
| 2015 |
Kumar V, Mahato RI. Delivery and targeting of miRNAs for treating liver fibrosis. Pharmaceutical Research. 32: 341-61. PMID 25186440 DOI: 10.1007/S11095-014-1497-X |
0.369 |
|
| 2014 |
Mittal A, Chitkara D, Behrman SW, Mahato RI. Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer. Biomaterials. 35: 7077-87. PMID 24836307 DOI: 10.1016/J.Biomaterials.2014.04.053 |
0.318 |
|
| 2014 |
Wen D, Chitkara D, Wu H, Danquah M, Patil R, Miller DD, Mahato RI. LHRH-conjugated micelles for targeted delivery of antiandrogen to treat advanced prostate cancer. Pharmaceutical Research. 31: 2784-95. PMID 24789451 DOI: 10.1007/S11095-014-1375-6 |
0.534 |
|
| 2014 |
Wang H, Li F, Du C, Wang H, Mahato RI, Huang Y. Doxorubicin and lapatinib combination nanomedicine for treating resistant breast cancer. Molecular Pharmaceutics. 11: 2600-11. PMID 24405470 DOI: 10.1021/Mp400687W |
0.322 |
|
| 2014 |
Kumar V, Mundra V, Mahato RI. Nanomedicines of Hedgehog inhibitor and PPAR-γ agonist for treating liver fibrosis. Pharmaceutical Research. 31: 1158-69. PMID 24249038 DOI: 10.1007/S11095-013-1239-5 |
0.36 |
|
| 2014 |
Chitkara D, Mittal A, Behrman SW, Mahato RI. Abstract 4488: Multi-functional, miR-205 complexed, gemcitabine conjugated nanomedicines for effective treatment of chemo-resistant pancreatic adenocarcinoma Cancer Research. 74: 4488-4488. DOI: 10.1158/1538-7445.Am2014-4488 |
0.322 |
|
| 2013 |
Wu H, Pagadala J, Yates CR, Miller D, Mahato RI. Synthesis and characterization of an anti-apoptotic immunosuppressive compound for improving the outcome of islet transplantation. Bioconjugate Chemistry. 24: 2036-44. PMID 24256337 DOI: 10.1021/Bc400369T |
0.342 |
|
| 2013 |
Mundra V, Wu H, Mahato RI. Genetically modified human bone marrow derived mesenchymal stem cells for improving the outcome of human islet transplantation. Plos One. 8: e77591. PMID 24204883 DOI: 10.1371/Journal.Pone.0077591 |
0.322 |
|
| 2013 |
Wu H, Wen D, Mahato RI. Third-party mesenchymal stem cells improved human islet transplantation in a humanized diabetic mouse model. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1778-86. PMID 23765442 DOI: 10.1038/Mt.2013.147 |
0.33 |
|
| 2013 |
Chitkara D, Mittal A, Behrman SW, Kumar N, Mahato RI. Self-assembling, amphiphilic polymer-gemcitabine conjugate shows enhanced antitumor efficacy against human pancreatic adenocarcinoma. Bioconjugate Chemistry. 24: 1161-73. PMID 23758084 DOI: 10.1021/Bc400032X |
0.333 |
|
| 2013 |
Mundra V, Gerling IC, Mahato RI. Mesenchymal stem cell-based therapy. Molecular Pharmaceutics. 10: 77-89. PMID 23215004 DOI: 10.1021/Mp3005148 |
0.305 |
|
| 2012 |
Mundra V, Lu Y, Danquah M, Li W, Miller DD, Mahato RI. Formulation and characterization of polyester/polycarbonate nanoparticles for delivery of a novel microtubule destabilizing agent. Pharmaceutical Research. 29: 3064-74. PMID 23054088 DOI: 10.1007/S11095-012-0881-7 |
0.484 |
|
| 2012 |
Pratap A, Singh S, Mundra V, Yang N, Panakanti R, Eason JD, Mahato RI. Attenuation of early liver fibrosis by pharmacological inhibition of smoothened receptor signaling. Journal of Drug Targeting. 20: 770-82. PMID 22994359 DOI: 10.3109/1061186X.2012.719900 |
0.782 |
|
| 2012 |
Danquah M, Singh S, Behrman SW, Mahato RI. Role of miRNA and cancer stem cells in chemoresistance and pancreatic cancer treatment. Expert Opinion On Drug Delivery. 9: 1443-7. PMID 22954290 DOI: 10.1517/17425247.2012.722079 |
0.565 |
|
| 2012 |
Chitkara D, Singh S, Kumar V, Danquah M, Behrman SW, Kumar N, Mahato RI. Micellar delivery of cyclopamine and gefitinib for treating pancreatic cancer. Molecular Pharmaceutics. 9: 2350-7. PMID 22780906 DOI: 10.1021/Mp3002792 |
0.591 |
|
| 2012 |
Singh S, Chitkara D, Mehrazin R, Behrman SW, Wake RW, Mahato RI. Chemoresistance in prostate cancer cells is regulated by miRNAs and Hedgehog pathway Plos One. 7. PMID 22768203 DOI: 10.1371/Journal.Pone.0040021 |
0.324 |
|
| 2012 |
Danquah M, Duke CB, Patil R, Miller DD, Mahato RI. Combination therapy of antiandrogen and XIAP inhibitor for treating advanced prostate cancer. Pharmaceutical Research. 29: 2079-91. PMID 22451249 DOI: 10.1007/S11095-012-0737-1 |
0.541 |
|
| 2012 |
Danquah M, Fujiwara T, Mahato RI. Lactic acid- and carbonate-based crosslinked polymeric micelles for drug delivery Journal of Polymer Science Part a: Polymer Chemistry. 51: 347-362. DOI: 10.1002/Pola.26392 |
0.541 |
|
| 2011 |
Li F, Danquah M, Singh S, Wu H, Mahato RI. Paclitaxel- and lapatinib-loaded lipopolymer micelles overcome multidrug resistance in prostate cancer. Drug Delivery and Translational Research. 1: 420-8. PMID 25786362 DOI: 10.1007/S13346-011-0042-2 |
0.571 |
|
| 2011 |
Wu H, Yoon AR, Li F, Yun CO, Mahato RI. RGD peptide-modified adenovirus expressing hepatocyte growth factor and X-linked inhibitor of apoptosis improves islet transplantation. The Journal of Gene Medicine. 13: 658-69. PMID 22095898 DOI: 10.1002/Jgm.1626 |
0.33 |
|
| 2011 |
Singh S, Narang AS, Mahato RI. Subcellular fate and off-target effects of siRNA, shRNA, and miRNA. Pharmaceutical Research. 28: 2996-3015. PMID 22033880 DOI: 10.1007/S11095-011-0608-1 |
0.639 |
|
| 2011 |
Ye Z, Mahato RI. Combining stem cells and genes for effective therapeutics. Molecular Pharmaceutics. 8: 1443-5. PMID 21962294 DOI: 10.1021/Mp200437M |
0.607 |
|
| 2011 |
Yang N, Singh S, Mahato RI. Targeted TFO delivery to hepatic stellate cells. Journal of Controlled Release : Official Journal of the Controlled Release Society. 155: 326-30. PMID 21763370 DOI: 10.1016/J.Jconrel.2011.06.037 |
0.674 |
|
| 2011 |
Wu H, Ye Z, Mahato RI. Genetically modified mesenchymal stem cells for improved islet transplantation. Molecular Pharmaceutics. 8: 1458-70. PMID 21707070 DOI: 10.1021/Mp200135E |
0.616 |
|
| 2011 |
Wu H, Lu W, Mahato RI. Mesenchymal stem cells as a gene delivery vehicle for successful islet transplantation. Pharmaceutical Research. 28: 2098-109. PMID 21499838 DOI: 10.1007/S11095-011-0434-5 |
0.341 |
|
| 2011 |
Pratap A, Panakanti R, Yang N, Lakshmi R, Modanlou KA, Eason JD, Mahato RI. Cyclopamine attenuates acute warm ischemia reperfusion injury in cholestatic rat liver: hope for marginal livers. Molecular Pharmaceutics. 8: 958-68. PMID 21491930 DOI: 10.1021/Mp200115V |
0.769 |
|
| 2011 |
Yang N, Mahato RI. GFAP promoter-driven RNA interference on TGF-β1 to treat liver fibrosis. Pharmaceutical Research. 28: 752-61. PMID 21347569 DOI: 10.1007/S11095-011-0384-Y |
0.619 |
|
| 2011 |
Lu W, Li F, Mahato RI. Poly(ethylene glycol)-block-poly(2-methyl-2-benzoxycarbonyl-propylene carbonate) micelles for rapamycin delivery: in vitro characterization and biodistribution. Journal of Pharmaceutical Sciences. 100: 2418-29. PMID 21264854 DOI: 10.1002/Jps.22467 |
0.318 |
|
| 2011 |
Li F, Mahato RI. RNA interference for improving the outcome of islet transplantation. Advanced Drug Delivery Reviews. 63: 47-68. PMID 21156190 DOI: 10.1016/J.Addr.2010.11.003 |
0.335 |
|
| 2011 |
Danquah MK, Zhang XA, Mahato RI. Extravasation of polymeric nanomedicines across tumor vasculature. Advanced Drug Delivery Reviews. 63: 623-39. PMID 21144874 DOI: 10.1016/J.Addr.2010.11.005 |
0.535 |
|
| 2010 |
Zhu L, Mahato RI. Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugation. Bioconjugate Chemistry. 21: 2119-27. PMID 20964335 DOI: 10.1021/Bc100346N |
0.384 |
|
| 2010 |
Panakanti R, Pratap A, Yang N, Jackson JS, Mahato RI. Triplex forming oligonucleotides against type α1(I) collagen attenuates liver fibrosis induced by bile duct ligation. Biochemical Pharmacology. 80: 1718-26. PMID 20816672 DOI: 10.1016/J.Bcp.2010.08.020 |
0.768 |
|
| 2010 |
Li F, Danquah M, Mahato RI. Synthesis and characterization of amphiphilic lipopolymers for micellar drug delivery. Biomacromolecules. 11: 2610-20. PMID 20804201 DOI: 10.1021/Bm100561V |
0.559 |
|
| 2010 |
Pratap A, Panakanti R, Yang N, Eason JD, Mahato RI. Inhibition of endogenous hedgehog signaling protects against acute liver injury after ischemia reperfusion. Pharmaceutical Research. 27: 2492-504. PMID 20737284 DOI: 10.1007/S11095-010-0246-Z |
0.757 |
|
| 2010 |
Wu H, Panakanti R, Li F, Mahato RI. XIAP gene expression protects β-cells and human islets from apoptotic cell death. Molecular Pharmaceutics. 7: 1655-66. PMID 20677802 DOI: 10.1021/Mp100070J |
0.779 |
|
| 2010 |
Wang DA, Mahato RI. Therapeutic cell delivery for in situ regenerative medicine. Advanced Drug Delivery Reviews. 62: 669-70. PMID 20420868 DOI: 10.1016/J.Addr.2010.04.008 |
0.332 |
|
| 2010 |
Li F, Lu Y, Li W, Miller DD, Mahato RI. Synthesis, formulation and in vitro evaluation of a novel microtubule destabilizer, SMART-100. Journal of Controlled Release : Official Journal of the Controlled Release Society. 143: 151-8. PMID 20060430 DOI: 10.1016/J.Jconrel.2009.12.028 |
0.319 |
|
| 2010 |
Danquah M, Fujiwara T, Mahato RI. Self-assembling methoxypoly(ethylene glycol)-b-poly(carbonate-co-L-lactide) block copolymers for drug delivery. Biomaterials. 31: 2358-70. PMID 20018369 DOI: 10.1016/J.Biomaterials.2009.11.081 |
0.546 |
|
| 2009 |
Mahato RI, Ye Z, Kim SW. Formation and use of water-soluble lipopolymer-pDNA and lipopeptide-pDNA complexes. Cold Spring Harbor Protocols. 2009: pdb.prot5306. PMID 20147051 DOI: 10.1101/Pdb.Prot5306 |
0.583 |
|
| 2009 |
Li F, Mahato RI. Bipartite vectors for co-expression of a growth factor cDNA and short hairpin RNA against an apoptotic gene. The Journal of Gene Medicine. 11: 764-71. PMID 19554613 DOI: 10.1002/Jgm.1357 |
0.338 |
|
| 2009 |
Danquah M, Li F, Duke CB, Miller DD, Mahato RI. Micellar delivery of bicalutamide and embelin for treating prostate cancer. Pharmaceutical Research. 26: 2081-92. PMID 19415464 DOI: 10.1007/S11095-009-9903-5 |
0.528 |
|
| 2009 |
Kim HA, Mahato RI, Lee M. Hypoxia-specific gene expression for ischemic disease gene therapy. Advanced Drug Delivery Reviews. 61: 614-22. PMID 19394379 DOI: 10.1016/J.Addr.2009.04.009 |
0.302 |
|
| 2009 |
Cheng K, Yang N, Mahato RI. TGF-beta1 gene silencing for treating liver fibrosis. Molecular Pharmaceutics. 6: 772-9. PMID 19388665 DOI: 10.1021/Mp9000469 |
0.608 |
|
| 2009 |
Mahato RI. Gene expression and silencing for improved islet transplantation. Journal of Controlled Release : Official Journal of the Controlled Release Society. 140: 262-7. PMID 19376168 DOI: 10.1016/J.Jconrel.2009.04.011 |
0.365 |
|
| 2009 |
Yang N, Ye Z, Li F, Mahato RI. HPMA polymer-based site-specific delivery of oligonucleotides to hepatic stellate cells. Bioconjugate Chemistry. 20: 213-21. PMID 19133717 DOI: 10.1021/Bc800237T |
0.76 |
|
| 2009 |
Panakanti R, Mahato RI. Bipartite vector encoding hVEGF and hIL-1Ra for ex vivo transduction into human islets. Molecular Pharmaceutics. 6: 274-84. PMID 19067524 DOI: 10.1021/Mp800183B |
0.773 |
|
| 2009 |
Panakanti R, Mahato RI. Bipartite adenoviral vector encoding hHGF and hIL-1Ra for improved human islet transplantation. Pharmaceutical Research. 26: 587-96. PMID 19002565 DOI: 10.1007/S11095-008-9777-Y |
0.776 |
|
| 2008 |
Cheng G, Zhu L, Mahato RI. Caspase-3 gene silencing for inhibiting apoptosis in insulinoma cells and human islets. Molecular Pharmaceutics. 5: 1093-102. PMID 18828606 DOI: 10.1021/Mp800093F |
0.358 |
|
| 2008 |
Ye Z, Mahato RI. Role of nanomedicines in cell-based therapeutics. Nanomedicine (London, England). 3: 5-8. PMID 18393661 DOI: 10.2217/17435889.3.1.5 |
0.563 |
|
| 2008 |
Chen Y, Mahato RI. siRNA pool targeting different sites of human hepatitis B surface antigen efficiently inhibits HBV infection. Journal of Drug Targeting. 16: 140-8. PMID 18274934 DOI: 10.1080/10611860701878750 |
0.339 |
|
| 2008 |
Li F, Mahato RI. iNOS gene silencing prevents inflammatory cytokine-induced beta-cell apoptosis. Molecular Pharmaceutics. 5: 407-17. PMID 18217711 DOI: 10.1021/Mp700145F |
0.345 |
|
| 2008 |
Chen Y, Cheng G, Mahato RI. RNAi for treating hepatitis B viral infection. Pharmaceutical Research. 25: 72-86. PMID 18074201 DOI: 10.1007/S11095-007-9504-0 |
0.305 |
|
| 2008 |
Ye Z, Mahato RI. Emerging trends in cell-based therapies. Preface. Advanced Drug Delivery Reviews. 60: 89-90. PMID 18029049 DOI: 10.1016/J.Addr.2007.10.001 |
0.586 |
|
| 2008 |
Zhu L, Ye Z, Cheng K, Miller DD, Mahato RI. Site-specific delivery of oligonucleotides to hepatocytes after systemic administration. Bioconjugate Chemistry. 19: 290-8. PMID 17850109 DOI: 10.1021/Bc070126M |
0.651 |
|
| 2007 |
Ye Z, Houssein HS, Mahato RI. Bioconjugation of oligonucleotides for treating liver fibrosis. Oligonucleotides. 17: 349-404. PMID 18154454 DOI: 10.1089/Oli.2007.0097 |
0.665 |
|
| 2007 |
Ye Z, Guntaka RV, Mahato RI. Sequence-specific triple helix formation with genomic DNA. Biochemistry. 46: 11240-52. PMID 17845009 DOI: 10.1021/Bi700580Y |
0.597 |
|
| 2007 |
Cheng K, Mahato RI. Gene modulation for treating liver fibrosis. Critical Reviews in Therapeutic Drug Carrier Systems. 24: 93-146. PMID 17725523 DOI: 10.1615/Critrevtherdrugcarriersyst.V24.I2.10 |
0.416 |
|
| 2007 |
De Paula D, Bentley MV, Mahato RI. Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting. Rna (New York, N.Y.). 13: 431-56. PMID 17329355 DOI: 10.1261/Rna.459807 |
0.328 |
|
| 2007 |
Jia X, Cheng K, Mahato RI. Coexpression of vascular endothelial growth factor and interleukin-1 receptor antagonist for improved human islet survival and function. Molecular Pharmaceutics. 4: 199-207. PMID 17256873 DOI: 10.1021/Mp060091S |
0.33 |
|
| 2006 |
Narang AS, Sabek O, Gaber AO, Mahato RI. Co-expression of vascular endothelial growth factor and interleukin-1 receptor antagonist improves human islet survival and function. Pharmaceutical Research. 23: 1970-82. PMID 16906455 DOI: 10.1007/s11095-006-9065-7 |
0.625 |
|
| 2006 |
Narang AS, Mahato RI. Biological and biomaterial approaches for improved islet transplantation. Pharmacological Reviews. 58: 194-243. PMID 16714486 DOI: 10.1124/Pr.58.2.6 |
0.648 |
|
| 2006 |
Ye Z, Cheng K, Guntaka RV, Mahato RI. Receptor-mediated hepatic uptake of M6P-BSA-conjugated triplex-forming oligonucleotides in rats. Bioconjugate Chemistry. 17: 823-30. PMID 16704223 DOI: 10.1021/Bc060006Z |
0.651 |
|
| 2006 |
Cheng K, Ye Z, Guntaka RV, Mahato RI. Enhanced hepatic uptake and bioactivity of type alpha1(I) collagen gene promoter-specific triplex-forming oligonucleotides after conjugation with cholesterol. The Journal of Pharmacology and Experimental Therapeutics. 317: 797-805. PMID 16452392 DOI: 10.1124/Jpet.105.100347 |
0.654 |
|
| 2005 |
Mahato RI, Cheng K, Guntaka RV. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA. Expert Opinion On Drug Delivery. 2: 3-28. PMID 16296732 DOI: 10.1517/17425247.2.1.3 |
0.314 |
|
| 2005 |
Cheng K, Ye Z, Guntaka RV, Mahato RI. Biodistribution and hepatic uptake of triplex-forming oligonucleotides against type alpha1(I) collagen gene promoter in normal and fibrotic rats. Molecular Pharmaceutics. 2: 206-17. PMID 15934781 DOI: 10.1021/Mp050012X |
0.656 |
|
| 2005 |
Ye Z, Cheng K, Guntaka RV, Mahato RI. Targeted delivery of a triplex-forming oligonucleotide to hepatic stellate cells. Biochemistry. 44: 4466-76. PMID 15766277 DOI: 10.1021/Bi047529J |
0.659 |
|
| 2005 |
Narang AS, Thoma L, Miller DD, Mahato RI. Cationic lipids with increased DNA binding affinity for nonviral gene transfer in dividing and nondividing cells. Bioconjugate Chemistry. 16: 156-68. PMID 15656587 DOI: 10.1021/Bc049818Q |
0.633 |
|
| 2004 |
Cheng K, Fraga D, Zhang C, Kotb M, Gaber AO, Guntaka RV, Mahato RI. Adenovirus-based vascular endothelial growth factor gene delivery to human pancreatic islets. Gene Therapy. 11: 1105-16. PMID 15238996 DOI: 10.1038/Sj.Gt.3302267 |
0.35 |
|
| 2004 |
Narang AS, Cheng K, Henry J, Zhang C, Sabek O, Fraga D, Kotb M, Gaber AO, Mahato RI. Vascular endothelial growth factor gene delivery for revascularization in transplanted human islets. Pharmaceutical Research. 21: 15-25. PMID 14984253 DOI: 10.1023/B:Pham.0000012147.52900.B8 |
0.639 |
|
| 2003 |
Mahato RI, Narang AS, Thoma L, Miller DD. Emerging trends in oral delivery of peptide and protein drugs. Critical Reviews in Therapeutic Drug Carrier Systems. 20: 153-214. PMID 14584523 DOI: 10.1615/Critrevtherdrugcarriersyst.V20.I23.30 |
0.623 |
|
| 2003 |
Mahato RI, Henry J, Narang AS, Sabek O, Fraga D, Kotb M, Gaber AO. Cationic lipid and polymer-based gene delivery to human pancreatic islets. Molecular Therapy : the Journal of the American Society of Gene Therapy. 7: 89-100. PMID 12573622 DOI: 10.1016/S1525-0016(02)00031-X |
0.672 |
|
| 2002 |
Wang DA, Narang AS, Kotb M, Gaber AO, Miller DD, Kim SW, Mahato RI. Novel branched poly(ethylenimine)-cholesterol water-soluble lipopolymers for gene delivery. Biomacromolecules. 3: 1197-207. PMID 12425656 DOI: 10.1021/Bm025563C |
0.637 |
|
| 2001 |
Benns JM, Maheshwari A, Furgeson DY, Mahato RI, Kim SW. Folate-PEG-folate-graft-polyethylenimine-based gene delivery. Journal of Drug Targeting. 9: 123-39. PMID 11697107 DOI: 10.3109/10611860108997923 |
0.328 |
|
| 2001 |
Mahato RI, Kim SW. Water-soluble lipopolymer for gene delivery. Bioconjugate Chemistry. 12: 337-45. PMID 11353530 DOI: 10.1021/Bc000120W |
0.309 |
|
| 2000 |
Mahato RI. Challenges of turning nucleic acids into therapeutics. Advanced Drug Delivery Reviews. 44: 79-80. PMID 11072106 DOI: 10.1016/S0169-409X(00)00086-7 |
0.332 |
|
| 2000 |
Han S, Mahato RI, Sung YK, Kim SW. Development of biomaterials for gene therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 2: 302-17. PMID 11020345 DOI: 10.1006/Mthe.2000.0142 |
0.309 |
|
| 2000 |
Maheshwari A, Mahato RI, McGregor J, Han So, Samlowski WE, Park JS, Kim SW. Soluble biodegradable polymer-based cytokine gene delivery for cancer treatment. Molecular Therapy : the Journal of the American Society of Gene Therapy. 2: 121-30. PMID 10947939 DOI: 10.1006/Mthe.2000.0105 |
0.347 |
|
| 2000 |
Mahato RI. Non-viral peptide-based approaches to gene delivery. Journal of Drug Targeting. 7: 249-68. PMID 10682905 DOI: 10.3109/10611869909085509 |
0.31 |
|
| 1999 |
Mahato RI, Smith LC, Rolland A. Pharmaceutical perspectives of nonviral gene therapy. Advances in Genetics. 41: 95-156. PMID 10494618 DOI: 10.1016/S0065-2660(08)60152-2 |
0.311 |
|
| 1998 |
Takakura Y, Mahato RI, Hashida M. Extravasation of macromolecules Advanced Drug Delivery Reviews. 34: 93-108. PMID 10837672 DOI: 10.1016/S0169-409X(98)00006-4 |
0.325 |
|
| 1997 |
Mahato RI, Rolland A, Tomlinson E. Cationic lipid-based gene delivery systems: pharmaceutical perspectives. Pharmaceutical Research. 14: 853-9. PMID 9244140 DOI: 10.1023/A:1012187414126 |
0.333 |
|
| 1997 |
Mahato RI, Takakura Y, Hashida M. Development of targeted delivery systems for nucleic acid drugs. Journal of Drug Targeting. 4: 337-57. PMID 9239575 DOI: 10.3109/10611869709017892 |
0.324 |
|
| 1997 |
Mahato RI, Takemura S, Akamatsu K, Nishikawa M, Takakura Y, Hashida M. Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine). Biochemical Pharmacology. 53: 887-95. PMID 9113108 DOI: 10.1016/S0006-2952(96)00880-5 |
0.332 |
|
| 1997 |
Takakura Y, Mahato RI, Yoshida M, Kanamaru T, Hashida M. Uptake characteristics of oligonucleotides in the isolated rat liver perfusion system. Antisense & Nucleic Acid Drug Development. 6: 177-83. PMID 8915502 DOI: 10.1089/Oli.1.1996.6.177 |
0.369 |
|
| 1997 |
Mahato RI, Takakura Y, Hashida M. Nonviral Vectors for In Vivo Gene Delivery: Physicochemical and Pharmacokinetic Considerations Critical Reviews in Therapeutic Drug Carrier Systems. 14: 40. DOI: 10.1615/Critrevtherdrugcarriersyst.V14.I2.20 |
0.347 |
|
| 1996 |
Yoshida M, Mahato RI, Kawabata K, Takakura Y, Hashida M. Disposition characteristics of plasmid DNA in the single-pass rat liver perfusion system. Pharmaceutical Research. 13: 599-603. PMID 8710753 DOI: 10.1023/A:1016058407671 |
0.336 |
|
| 1996 |
Mahato RI, Kawabata K, Nomura T, Takakura Y, Hashida M. Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes. Journal of Pharmaceutical Sciences. 84: 1267-71. PMID 8587040 DOI: 10.1002/Jps.2600841102 |
0.357 |
|
| 1996 |
Mahato RI, Kawabata K, Takakura Y, Hashida M. In vivo disposition characteristics of plasmid DNA complexed with cationic liposomes. Journal of Drug Targeting. 3: 149-57. PMID 7496728 DOI: 10.3109/10611869509059214 |
0.354 |
|
| 1996 |
Takakura Y, Mahato RI, Nishikawa M, Hashida M. Control of pharmacokinetic profiles of drug—macromolecule conjugates Advanced Drug Delivery Reviews. 19: 377-399. DOI: 10.1016/0169-409X(96)00010-5 |
0.316 |
|
| 1996 |
Hashida M, Mahato RI, Kawabata K, Miyao T, Nishikawa M, Takakura Y. Pharmacokinetics and targeted delivery of proteins and genes Journal of Controlled Release. 41: 91-97. DOI: 10.1016/0168-3659(96)01360-0 |
0.365 |
|
| Show low-probability matches. |